Xeris Biopharma Holdings Inc (XERS)
2.925
-0.04
(-1.18%)
USD |
NASDAQ |
Sep 20, 16:00
2.92
0.00 (0.00%)
After-Hours: 18:54
Xeris Biopharma Holdings Total Assets (Quarterly): 331.73M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 331.73M |
| March 31, 2024 | 336.62M |
| December 31, 2023 | 322.60M |
| September 30, 2023 | 327.78M |
| June 30, 2023 | 328.78M |
| March 31, 2023 | 321.36M |
| December 31, 2022 | 344.52M |
| September 30, 2022 | 303.02M |
| June 30, 2022 | 318.62M |
| March 31, 2022 | 337.62M |
| December 31, 2021 | 304.36M |
| September 30, 2021 | 131.26M |
| June 30, 2021 | 151.50M |
| March 31, 2021 | 167.64M |
| Date | Value |
|---|---|
| December 31, 2020 | 159.15M |
| September 30, 2020 | 170.39M |
| June 30, 2020 | 165.81M |
| March 31, 2020 | 116.46M |
| December 31, 2019 | 108.99M |
| September 30, 2019 | 128.10M |
| June 30, 2019 | 133.89M |
| March 31, 2019 | 160.97M |
| December 31, 2018 | 120.03M |
| September 30, 2018 | 137.59M |
| June 30, 2018 | 138.26M |
| March 31, 2018 | 61.56M |
| December 31, 2017 | 45.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
108.99M
Minimum
Dec 2019
344.52M
Maximum
Dec 2022
243.82M
Average
303.69M
Median
Total Assets (Quarterly) Benchmarks
| Zoetis Inc | 14.16B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 351.02M |
| Shareholders Equity (Quarterly) | -19.29M |
| Debt to Equity Ratio | -11.95 |
| Current Ratio | 2.256 |
| Net Debt Paydown Yield | -2.56% |